MultiHance 用於乳房顯影之相關文獻
Grimm LJ, Anderson AL, Baker JA, Johnson KS, Walsh R, Yoon SC, Ghate SV.Interobserver Variability Between Breast Imagers Using the Fifth Edition of the BI-RADS MRI Lexicon.
AJR Am J Roentgenol. 2015 May;204(5):1120-4. doi: 10.2214/AJR.14.13047.
www.ncbi.nlm.nih.gov/pubmed/25905951
Gilbert FJ, van den Bosch HC, Petrillo A, Siegmann K, Heverhagen JT, Panizza P, Gehl HB, Pediconi F, Diekmann F, Peng WJ, Ma L, Sardanelli F, Belli P, Corcione S, Zechmann CM, Faivre-Pierret M, Martincich L. Comparison of gadobenate dimeglumine-enhanced breast MRI and gadopentetate dimeglumine-enhanced breast MRI with mammography and ultrasound for the detection of breast cancer. J Magn Reson Imaging. 2014 May;39(5):1272-86.
www.ncbi.nlm.nih.gov/pubmed/25006633
Yi A, Cho N, Im SA, Chang JM, Kim SJ, Moon HG, Han W, Park IA, Noh DY, Moon WK. Survival outcomes of breast cancer patients who receive neoadjuvant chemotherapy: association with dynamic contrast-enhanced MR imaging with computer-aided evaluation. Radiology. 2013 Sep;268(3):662-72.
www.ncbi.nlm.nih.gov/pubmed/23592770
Pediconi F, Kubik-Huch R, Chilla B, Schwenke C, Kinkel K. Intra-individual randomised comparison of gadobutrol 1.0 M versus gadobenate dimeglumine 0.5 M in patients scheduled for preoperative breast MRI. Eur Radiol. 2013 Jan;23(1):84-92.
www.ncbi.nlm.nih.gov/pubmed/22797979
Londero V, Zuiani C, Linda A, Girometti R, Bazzocchi M, Sardanelli F High-risk breast lesions at imaging-guided needle biopsy: usefulness of MRI for treatment decision. AJR Am J Roentgenol. 2012 Aug;199(2):W240-50.
www.ncbi.nlm.nih.gov/pubmed/22826427
Pages EB, Millet I, Hoa D, Doyon FC, Taourel P. Undiagnosed breast cancer at MR imaging: analysis of causes. Radiology. 2012 Jul;264(1):40-50.
Wang QJ, Wang Y, Xu X, Xiao H, Ma L. [Efficacy of gadobenate dimeglumine vs gadopentetate dimeglumine in contrast- enhanced magnetic resonance imaging for diagnosis of solitary brain metastases]. Nan Fang Yi Ke Da Xue Xue Bao
www.ncbi.nlm.nih.gov/pubmed/22200693
El Khouli RH, Macura KJ, Kamel IR, Jacobs MA, Bluemke DA. 3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis. AJR Am J Roentgenol. 2011 Dec;197(6):1498-505
www.ncbi.nlm.nih.gov/pubmed/22109308
Carbonaro LA, Pediconi F, Verardi N, Trimboli RM, Calabrese M, Sardanelli F. Breast MRI using a high-relaxivity contrast agent: an overview. AJR Am J Roentgenol. 2011 Apr;196(4):942-55.
www.ncbi.nlm.nih.gov/pubmed/21427349
Martincich L, Faivre-Pierret M, Zechmann CM, Corcione S, van den Bosch HC, Peng WJ, Petrillo A, Siegmann KC, Heverhagen JT, Panizza P, Gehl HB, Diekmann F, Pediconi F, Ma L, Gilbert FJ, Sardanelli F, Belli P, Salvatore M, Kreitner KF, Weiss CM, Zuiani C. Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for Breast MR imaging (DETECT Trial). Radiology. 2011 Feb;258(2):396-408.
www.ncbi.nlm.nih.gov/pubmed/21163915
Ei Khouli RH, Jacobs MA, Mezban SD, Huang P, Kamel IR, Macura KJ, Bluemke DA. Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging. Radiology. 2010 Jul;256(1):64-73.
www.ncbi.nlm.nih.gov/pubmed/20574085
Carbonaro LA, Verardi N, Di Leo G, Sardanelli F. Handling a high relaxivity contrast material for dynamic breast MR imaging using higher thresholds for the initial enhancement. Invest Radiol. 2010 Mar;45(3):114-20.
www.ncbi.nlm.nih.gov/pubmed/20065856
Sardanelli F, Fausto A, Esseridou A, Di Leo G, Kirchin MA. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance. Invest Radiol. 2008 Apr;43(4):236-42.
www.ncbi.nlm.nih.gov/pubmed/18340247
Pediconi F1, Catalano C, Occhiato R, Venditti F, Fraioli F, Napoli A, Kirchin MA, Passariello R. Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine. Radiology. 2005 Oct;237(1):45-56. Epub 2005 Aug 26.
www.ncbi.nlm.nih.gov/pubmed/16126926
Sardanelli F1, Iozzelli A, Fausto A, Carriero A, Kirchin MA. Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity. Radiology. 2005 Jun;235(3):791-7. Epub 2005 Apr 21.
www.ncbi.nlm.nih.gov/pubmed/15845796
Knopp MV1, Bourne MW, Sardanelli F, Wasser MN, Bonomo L, Boetes C, Müller-Schimpfle M, Hall-Craggs MA, Hamm B, Orlacchio A, Bartolozzi C, Kessler M, Fischer U, Schneider G, Oudkerk M, Teh WL, Gehl HB, Salerio I, Pirovano G, La Noce A, Kirchin MA, Spinazzi A. Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine. AJR Am J Roentgenol. 2003 Sep;181(3):663-76.